Charts Coya Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-06 EDT			5-day change	1st Jan Change
4.850 ^USD	0.00%		-3.58%	-16.38%

10-05	Coya Therapeutics, Inc. Completes Full Enrollment In Phase 2/3 ALSTARS Trial Of COYA 302 For The Treatment Of ALS	CI
09-15	Coya Therapeutics Enrolls 100th Participant In Phase 2/3 ALSTARS Trial Of COYA 302 For Treatment Of ALS	CI

NasdaqUSD

Markets		Quality
Nasdaq	COYA	Delayed
CBOE	COYA	Real-time

ProRealTime Chart